Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 2Sarcoma 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1Breast 1

Conditions

Lymphoma 8Lymphoma, Large B-Cell, Diffuse 6Hodgkin Disease 6Lymphoma, Follicular 3Breast Neoplasms 3Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Triple Negative Breast Neoplasms 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroendocrine Tumors 1Mycosis Fungoides 1Mesothelioma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Glioblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

tazemetostat 2Pemetrexed 2Cisplatin 2ruxolitinib 1ribociclib 1belinostat 1avelumab 1abemaciclib 1Sirolimus 1Rifampin 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Midazolam 1Letrozole 1LY3023414 1Itraconazole 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Fulvestrant 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxepin 1Biological Therapy 14-(3-fluoropropyl)glutamic acid 1(4S)-4-(3-(18F)fluoropropyl)-L-glutamate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Fluorodeoxyglucose F18 × Lymphoid × Clear all
NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡